Top Markets
Coin of the day
Bellicum Pharmaceuticals, Inc. Bellicum Pharmaceuticals, Inc.

Bellicum Pharmaceuticals, Inc.

BLCM
Κατάταξη σε μετοχές #38880
Bellicum Pharmaceuticals, Inc. (BLCM) operates as a clinical-stage... Bellicum Pharmaceuticals, Inc. (BLCM) operates as a clinical-stage biopharmaceutical firm dedicated to pioneering and advancing innovative cellular immunotherapies. Its primary objective is to combat blood cancers and solid tumors across domestic and global markets. Among its pipeline of experimental therapies are two key GoCAR-T candidates currently undergoing Phase 1/2 clinical evaluations. BPX-601, an autologous therapy, targets solid tumors that exhibit the prostate stem cell antigen. Additionally, BPX-603, a dual-switch GoCAR-T treatment, is being investigated for solid tumors characterized by the human epidermal growth factor receptor 2 (HER2) antigens. The company also features Rivo-cel, an allogeneic T cell therapy designed to improve patient prognoses in cases of leukemias, lymphomas, and various inherited blood disorders. Bellicum maintains strategic partnerships and licensing arrangements with several entities, including Adaptimmune Therapeutics plc, Agensys, Inc., BioVec Pharma, Inc., ARIAD Pharmaceuticals, Inc., and Baylor College of Medicine. Established in 2004, the company's corporate headquarters are located in Houston, Texas.
Τιμή μετοχής
$0.07475
Τελευταίος συγχρονισμός: 2024-03-04
Κεφαλαιοποίηση
$755.60K
Αλλαγή (1 ημέρα)
-6.68%
Αλλαγή (1 έτος)
0.00%
Χώρα
US
Εμπόριο Bellicum Pharmaceuticals, Inc. (BLCM)

Κατηγορία

Ιστορικό τιμής μετοχής για την Bellicum Pharmaceuticals, Inc. (BLCM)
Υψηλότερη τιμή κλεισίματος: $0.08 στις 2024-03-01

Χαμηλότερη τιμή κλεισίματος: $214.46 στις 2014-12-01
Ιστορικό τιμής μετοχής της Bellicum Pharmaceuticals, Inc. από 2014 έως 2026
Ετήσια απόδοση τιμής μετοχής
Έτος Απόδοση
2024 -58.98%
2023 -77.47%
2022 -48.69%
2021 -48.79%
2020 -67.81%
2019 -72.37%
2018 -59.58%
2017 -43.00%
2016 -22.19%
2015 -6.78%
2014 0.00%
Τιμή μετοχής για παρόμοιες εταιρείες ή ανταγωνιστές
Εταιρεία Τιμή μετοχής Μεταβολή 1Έτ% Χώρα
$507.69 30.08%
US
$848.55 30.06%
NL
$731.69 7.13%
CH
$1.07K -6.40%
KR
$251.82 11.25%
BE